Placenta-specific gene activation and inactivation using integrase-defective lentiviral vectors with the Cre/LoxP system

Genesis

Volumn 47, Issue 12, 2009, Pages 793-798

  Morioka, Yuka ^a   Isotani, Ayako ^a   Oshima, Robert G ^b   Okabe, Masaru ^a   Ikawa, Masahito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Adenoviral; Conditional; Cre; Integrase defective; Knockout; Lentivirus; Placenta

Indexed keywords

CELL PROTEIN; CRE RECOMBINASE; INTEGRASE DEFECTIVE LENTIVIRUS VECTOR; LENTIVIRUS VECTOR; PROTEIN LOXP; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLASTOCYST; CELL TYPE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; FEMALE; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENETIC RECOMBINATION; GENETIC REGULATION; GENETIC TRANSDUCTION; LETHALITY; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; REPORTER GENE; WILD TYPE;

ANIMALS; BINDING SITES; BLASTOCYST; DEFECTIVE VIRUSES; EMBRYO, MAMMALIAN; FEMALE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INTEGRASES; LENTIVIRUS; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; PLACENTA; PREGNANCY; RECOMBINATION, GENETIC; TRANSFECTION;

LENTIVIRUS; MUS;

EID: 73649117105     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20563     Document Type: Article

References (24)

1. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, Valladares A, Perez L, Klein R, Nebreda AR. 2000. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116.
2. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585-595.
3. Cross JC. 2005. How to make a placenta: mechanisms of trophoblast cell differentiation in mice - A review. Placenta 26 Suppl A:S3-S9.
4. Engelman A. 1999. In vivo analysis of retroviral integrase structure and function. Adv Virus Res 52:411-426.
5. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. 2001. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 154:544-556.
6. Georgiades P, Cox B, Gertsenstein M, Chawengsaksophak K, Rossant J. 2007. Trophoblast-specific gene manipulation using lentivirus-based vectors. Biotechniques 42:317, 318, 320, 322-325.
7. Gordon JW. 2002. Adenovirus gene transfer vector toxicity to mouse embryos: implications for human IVF. Hum Reprod 17:2380-2387.
8. Killebrew DA, Troelstrup D, Shiramizu B. 2004. Preferential HIV-1 integration sites in macrophages and HIV-associated malignancies. Cell Mol Biol (Noisy-le-grand)50 Online Pub:OL581-589.
9. Matsumura H, Hasuwa H, Inoue N, Ikawa M, Okabe M. 2004. Lineage-specific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain. Biochem Biophys Res Commun 321:275-279.
10. Nagy A. 2003. Production of chimeras. In: Nagy A, Vintersten K, Behringer R, editors. Manipulating the mouse embryo: A laboratory manual, 3rd ed. New York: Cold Spring Harbor Laboratory Press. pp 453-506.
11. Naiche LA, Papaioannou VE. 2007. Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 45:768-775.
12. Nightingale SJ, Hollis RP, Pepper KA, Petersen D, Yu XJ, Yang C, Bahner I, Kohn DB. 2006. Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13:1121-1132.
13. Okada Y, Ueshin Y, Hasuwa H, Takumi K, Okabe M, Ikawa M. 2009. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors. Genesis 47:217-223.
14. Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, Oh-Hora M, Mori Y, Ogata M, Oshima RG, Okabe M, Ikawa M. 2007. Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat Biotechnol 25:233-237.
15. Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C. 2006. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci USA 103:17684-17689.
16. Rossant J, Cross JC. 2001. Placental development: Lessons from mouse mutants. Nat Rev Genet 2:538-548.
17. Sarkis C, Philippe S, Mallet J, Serguera C. 2008. Non-integrating lentiviral vectors. Curr Gene Ther 8:430-437.
18. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR. 2000. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97:13702-13707.
19. Schmidt-Supprian M, Rajewsky K. 2007. Vagaries of conditional gene targeting. Nat Immunol 8:665-668.
20. Tynan JA, Wen F, Muller WJ, Oshima RG. 2005. Ets2-dependent microenvironmental support of mouse mammary tumors. Oncogene 24:6870-6876.
21. Wen F, Tynan JA, Cecena G, Williams R, Munera J, Mavrothalassitis G, Oshima RG. 2007. Ets2 is required for trophoblast stem cell self-renewal. Dev Biol 312:284-299.
22. Wenzel PL, Leone G. 2007. Expression of Cre recombinase in early diploid trophoblast cells of the mouse placenta. Genesis 45:129-134.
23. Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z, Oshima RG. 1998. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev 12:1315-1326.
24. Yu Y, Bradley A. 2001. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2:780-790.